Last reviewed · How we verify

NCT05605600

Translation of the International Consensus Definition of LARS Into a Bowl Dysfunction Severity Scoring Tool (New LARS Score)

Completed Last updated 5 April 2023
What this trial tests

trial in Low Anterior Resection Syndrome in 8 participants. Completed in 31 March 2023.

Timeline
3 October 2022
Primary endpoint
31 March 2023
31 March 2023

Quick facts

Lead sponsorCardiff and Vale University Health Board
StatusCompleted
Study typeOBSERVATIONAL
Enrollment8
Start date3 October 2022
Primary completion31 March 2023
Estimated completion31 March 2023
Sites1 location across United Kingdom

Conditions studied

Sponsor

Cardiff and Vale University Health Board

Who can join

18 and older, any sex, with Low Anterior Resection Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to develop a new severity scoring tool for Low Anterior Resection Syndrome (LARS) drawing on the international consensus criteria for LARS as well as opinions of patients with lived-experience of LARS.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Low Anterior Resection Syndrome

Currently open trials in the same condition.

Other Cardiff and Vale University Health Board trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05605600.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing